Discover the latest in health: evidence‑based wellness tips, medical breakthroughs, nutrition guidance, fitness insights, and expert advice for a healthier, happier life.
The Institute of Allergology and Immunology (IAI) in Sri Lanka has taken a significant step forward in the field of allergy and immunology with the inauguration of its modern state-of-the-art facility. Officially opened on January 28, 2025, this four-storey building is situated within the premises of the Faculty of Medical Sciences at the University of Sri Jayewardenepura, marking a pivotal moment for research, education, and clinical care in these crucial medical fields.
Founded by prominent figures in immunology and allergy research, including Prof. Neelika Malavige and Prof. Chandima Jeewandara, the IAI aims to address a long-standing gap in the country’s medical landscape. Prof. Malavige highlighted the institute’s focus on three essential areas: advancing research, enhancing education, and providing clinical care for individuals affected by allergies and immune-related conditions.
Prior to the establishment of the IAI, research in this domain was limited, often conducted in makeshift facilities. Prof. Malavige recounted the humble beginnings of their work, which began in a small house in Gangodawila, Nugegoda, and progressed through various phases, including shared spaces with the Family Practice Centre. The move to a dedicated facility represents a culmination of years of effort and commitment.
Building a Sustainable Future
The journey to this state-of-the-art facility was fraught with challenges, from securing funding to navigating bureaucratic hurdles. The IAI’s establishment follows a merger of the Centre for Dengue Research and the Centre for Primary Care and Allergy Research, which were initially separate entities. This consolidation was aimed at improving efficiency and fostering international collaboration.
As the IAI continues to evolve, sustainability remains a critical focus. The institute was built at a cost of Rs. 4.5 billion, with funding coming from a blend of government contributions and competitive research grants, ensuring financial independence. Prof. Jeewandara emphasized that their funding strategy allows the IAI to operate without placing a burden on the national treasury.
Research and Clinical Services
One of the standout features of the IAI is its commitment to cutting-edge research and diagnostic capabilities. The institute houses advanced equipment, including the Phadia 250, which is the only device of its kind in Sri Lanka that can detect allergen-specific IgE, aiding in the identification of allergies.
As a national referral center for allergic diseases, the IAI not only provides clinical services but also engages in extensive research. Current projects explore various aspects of allergies and infectious diseases, such as dengue, COVID-19, and tuberculosis, as well as developing new diagnostic tools and treatment methods. The institute’s research agenda is further supported by international partnerships with prestigious institutions like Oxford University and the World Health Organization.
Future Prospects
Looking ahead, the IAI has ambitious plans for education and training programs, offering degrees ranging from B.Sc to PhD and MD. The institute is also poised to create significant contributions to the field of allergy and immunology through ongoing research initiatives and collaborations with industry partners.
As of 2024, the IAI has registered over 2,000 patients, with more than 1,000 epinephrine auto-injectors distributed to those in need. The institute’s goals are clear: to enhance the quality of life for patients, facilitate early detection of epidemics, and develop cost-effective interventions tailored to the local context.
Prof. Jeewandara encapsulated the institute’s mission, stating, “We want solutions suitable for our country and our people and not ‘imported solutions.'” This forward-thinking approach positions the IAI as a vital player in addressing public health challenges in Sri Lanka and beyond.
As the IAI progresses, it will not only contribute to advancing the fields of allergy and immunology but also play a crucial role in shaping healthcare policies and practices in Sri Lanka. The ongoing developments at the IAI are a testament to the dedication and resilience of its leadership and staff, paving the way for a healthier future.
For more details on the IAI and its programs, visit the University of Sri Jayewardenepura.